Robert Byrne
Associate |
Dublin
+353 1920 2111
[email protected]
Ten Earlsfort Terrace
Dublin 2
D02 T380
Ireland
Robert is an associate in our Competition and Regulated Markets Group.
Insights Blog
Ireland’s Programme for Government 2025: the Life Sciences and Healthcare lens
21/01/2025
Insights blog
Health Technology Assessment Regulation – Applies as of 12 January 2025
09/01/2025
Insights blog
Medical Devices Regulations – obligation to notify supply issues commences on 10 January 2025
09/01/2025
Insights blog
Related Content
Foreign Investment Screening Regime in Ireland to commence on 6 January 2025
20/12/2024
Briefing
The EU Rings in New Changes for Product Liability and Product Safety
18/12/2024
Briefing
HSE and IPHA announce model Clinical Trial Agreement for tripartite clinical trials
29/05/2024
Update
Arthur Cox advises Chanelle Pharma on sale to Exponent
07/02/2024
Deals
Arthur Cox contributes to IBA’s Comparative Legal Guide on Telemedicine
09/06/2023
Publication